Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03079856 · ClinicalTrials.gov registry record · NA

Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER

A NA study of Drug Use and Sex Behavior, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
63
Enrollment target
1
Study location

NCT03079856 is a NA study of Drug Use and Sex Behavior that has completed, run by University of Michigan. The registered enrollment target is 63 participants, below the 221-participant average among 25 other Drug Use trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03079856, a NA study of Drug Use and Sex Behavior, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

This project will develop a technology-augmented HIV and substance use risk reduction intervention for delivery in the Emergency Department, a medical setting where at-risk emerging adults who use drugs and engage in HIV-related risk behaviors are likely to present.

Conditions Studied

Interventions

  • BEHAVIORAL Brief Intervention

Study Locations (1)

Michigan

  • Hurley Medical Center - Flint

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2017-10-09
Est. Completion 2018-08-13
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT03079856

The ClinicalTrials.gov registry entry for NCT03079856 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 25 other Drug Use trials with a reported enrollment target (71% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Drug Use appearing as the primary indexed condition, and to 1 intervention - of which Brief Intervention is the first listed.

NCT03079856 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03079856 about?

NCT03079856 is a clinical study titled "Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER". This project will develop a technology-augmented HIV and substance use risk reduction intervention for delivery in the Emergency Department, a medical setting where at-risk emerging adults who use drugs and engage in HIV-related risk behaviors are likely to present.

What is the current status of trial NCT03079856?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2017-10-09. Estimated completion is 2018-08-13.

What conditions does trial NCT03079856 study?

This clinical trial studies the following conditions: Drug Use, Sex Behavior.

What interventions are being tested in trial NCT03079856?

The interventions under investigation include: Brief Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03079856?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03079856 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Drug Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.